ADC Therapeutics SA Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ADC Therapeutics SA stock issued during period, value, new issues for the quarter ending 2025-12-31 was $43.07M.
- ADC Therapeutics SA stock issued during period, value, new issues for the quarter ending 2025-09-30 was $0.00.
- ADC Therapeutics SA stock issued during period, value, new issues for the quarter ending 2025-06-30 was $42.38M, a 29.96% decline year-over-year.
- ADC Therapeutics SA stock issued during period, value, new issues for the quarter ending 2024-12-31 was $0.00.
- ADC Therapeutics SA stock issued during period, value, new issues for fiscal 2025 was $85.44M, a 41.22% increase from fiscal 2024.
- ADC Therapeutics SA stock issued during period, value, new issues for fiscal 2024 was $60.51M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $43.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $85.44M 10-K · filed 2026-03-10 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | |
| 2025-06-30 | $42.38M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $60.51M 10-K · filed 2026-03-10 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | |
| 2024-06-30 | $60.51M 10-Q · filed 2025-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |